Evidence map›Paper›PMID 38367904›Full record

ArticleJournal of cardiac failure2024

Genetic Interleukin-6 Receptor Variant Is Not Associated With Rejection and Mortality After Heart Transplantation.

Kaushik Amancherla, Kelly H Schlendorf, Caitlyn Vlasschaert, Brandon D Lowery, Quinn S Wells, Sarah B See, Emmanuel Zorn, Paolo C Colombo, Muredach P Reilly, Joann Lindenfeld and 6 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of cardiac failure, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Kaushik AmancherlaDivision of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: kaushik.amancherla@vumc.org.
Kelly H SchlendorfDivision of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Caitlyn VlasschaertDepartment of Medicine, Queen's University, Kingston, Ontario, Canada.
Brandon D LoweryVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, Tennessee.
Quinn S WellsDivision of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee.
Sarah B SeeColumbia Center for Translational Immunology, Columbia University Medical Center, New York, New York.
Emmanuel ZornColumbia Center for Translational Immunology, Columbia University Medical Center, New York, New York.
Paolo C ColomboDivision of Cardiology, Columbia University Medical Center, New York, New York.
Muredach P ReillyDivision of Cardiology, Columbia University Medical Center, New York, New York.
Joann LindenfeldDivision of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Nir UrielDivision of Cardiology, Columbia University Medical Center, New York, New York.
Ravi V ShahDivision of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Jane E FreedmanDivision of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Javid MoslehiSection of Cardio-Oncology and Immunology (JM), University of California San Francisco, San Francisco, California.
Alex G BickDivision of Genetic Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Kevin ClerkinDivision of Cardiology, Columbia University Medical Center, New York, New York.

Funding

Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
Pharmacogenomics of Arrhythmia TherapyU19HL065962 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RODEN, DAN M · 2010 to 2014
$17.4M
Understanding and preventing HLA-associated drug reactionsP50GM115305 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RODEN, DAN M · 2015 to 2019
$13.0M
The Genetic Epemiology of Multiple SclerosisR01NS032830 · NINDS · VANDERBILT UNIVERSITY · PI HAINES, JONATHAN L · 1995 to 2010
$8.9M
Epidemiologic Architecture for Genes Linked to Environment (EAGLE)U01HG004798 · NHGRI · VANDERBILT UNIVERSITY · PI CRAWFORD, DANA C · 2008 to 2013
$8.8M
VESPA: Vanderbilt Electronic Systems for Pharmacogenomic AssessmentRC2GM092618 · NIGMS · VANDERBILT UNIVERSITY · PI DENNY, JOSHUA C., RODEN, DAN M · 2009 to 2010
$6.4M
Immunologic and Antigenic Drivers of Immune Checkpoint Inhibitor-Associated MyocarditisR01HL156021 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Justin M Balko, Javid J Moslehi · 2021 to 2026
$4.9M
Vanderbilt Genome Electronic Records ProjectU01HG006378 · NHGRI · VANDERBILT UNIVERSITY · PI RODEN, DAN M · 2011 to 2014
$4.0M
[18F]F-AraG as an imaging biomarker for early diagnosis and monitoring of cardiotoxicity related to doxorubicin and immune check point inhibitor therapyR01HL160688 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Jelena Levi, Youngho Seo · 2022 to 2026
$3.4M
Novel mechanisms and predictors of VEGF receptor inhibitor-associated hypertensionR01HL141466 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MOSLEHI, JAVID J · 2019 to 2023
$3.3M
NCATS NIH HHS UL1 TR000445NCATS NIH HHS UL1 TR002243NCRR NIH HHS S10 RR025141NCRR NIH HHS UL1 RR024975NHGRI NIH HHS U01 HG004798NHGRI NIH HHS U01 HG006378NHLBI NIH HHS K23 HL148528NHLBI NIH HHS K23 HL166960NHLBI NIH HHS L30 HL165555NHLBI NIH HHS R01 HL141466NHLBI NIH HHS R01 HL155990NHLBI NIH HHS R01 HL156021NHLBI NIH HHS R01 HL160688NHLBI NIH HHS U19 HL065962NICHD NIH HHS R01 HD074711NIGMS NIH HHS P50 GM115305NIGMS NIH HHS RC2 GM092618NIH HHS DP5 OD029586NIH HHS S10 OD017985NIH HHS S10 OD025092NINDS NIH HHS R01 NS032830
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Graft RejectionHeart TransplantationReceptors, Interleukin-6AdultFemaleGenetic VariationHumansMaleMiddle AgedReceptors, Interleukin-6

Identifiers

PMID38367904
PMCPMC11745565

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.